Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D-Cycloserine Enhancement of CBT for Smoking Cessation
NCT00827281Phase 2Withdrawn
- Start
- Aug 2008
- Primary completion
- Jul 2015
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of d-cycloserine in nicotine dependence. Planned start Aug 2008; status: withdrawn.
02
Drugs
d-cycloserine
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT00827281.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00827281.